Carolinas Center for Parkinson's Disease and Movement Disorders is dedicated to helping patients with movement disorders maximize their independence and quality of life. Our center offers a comprehensive, team-oriented approach to patient care that includes physicians, physical therapists, occupational therapists, speech therapists, a social worker, counseling for depression/anxiety, a dietitian and an exercise consultant.
Sanjay S. Iyer, MD, Director of Carolinas Center for Parkinson Disease and Movement Disorders, and Danielle E. Englert, MD evaluate and treat patients with all movement disorders in a learning environment that promotes clinical and basic science research.
|Movement Disorders treated at our Center include:
- Parkinson's disease
- Other Parkinsonian syndromes
- Essential tremor and other types of tremor
- Drug-induced movement disorders
- Huntington's disease
- Tics/Tourette's syndrome
- Restless Legs syndrome
- Blepharospasm and hemifacial spasm
|Watch the video on Movement Disorders
Carolinas Center for Parkinson's Disease and Movement Disorders offers a range of services, from early diagnosis and treatment to more advanced therapeutic options such as Deep Brain Stimulation (DBS) therapy and botulinum toxin injections for movement disorders and pain. Deep Brain Stimulation therapy is a surgical option primarily for the treatment of Parkinson's disease, essential tremor,and dystonia.
The Deep Brain Stimulation team consists of multiple dedicated members. Dr. Englert and Dr. Iyer work closely with a neurosurgeon, Martin Henegar, MD, as well as neuropsychologists, physical therapists, speech therapists, occupational therapists and social workers. Our goal is to implement the latest technology to ensure our patients the best comprehensive care possible.
For more information about our services for Parkinson's disease and movement disorders, please call 704-446-1900. Please view the video at right to learn more about RENEW Carolinas, a community-based neurowellness program for people with Parkinson's disease.
Clinical trials available for Parkinson's disease and movement disorders patients
|SANDANTE: Study to Assess the Safety and Clinical Benefit of Rasagiline as an Add on Therapy to Stable Dose of Dopamine Agonists in the Treatment of Early Parkinson's Disease
||The purpose of this study is to test the safety and effectiveness of the of the study drug, rasagiline, compared to a placebo for treatment of PD, when taken with a dopamine agonist medication.
View Consent Form
|NEUPRO: Named Patient Program with Rotigotine Transdermal System
||The objective of this named patient program is to allow investigators to continue to supply rotigotine transdermal system to patients who are currently taking rotigotine and have a documented medical necessity to continue treatment with the drug.
View Consent Form
|Efficacy and Safety Study of Preladenant in Subjects with Moderate to Severe Parkinson's Disease.
||The purpose of this study is to evaluate how effective, how safe and how well tolerated a range of preladenant doses compares with placebo in subjects with moderate to severe PD.